🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to assess safety of pan-metastases direc...
Status
Recruiting
Location
Centre Léon Bérard
Start Date
2024-07-11
Trial ID
NCT06439888
Treatments Being Tested
This research is being done to see if we can improve the outcome of prostat...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2022-10-18
Trial ID
NCT05223803
Treatments Being Tested
The prognosis for patients with metastatic breast cancer has improved conti...
Status
Completed
Location
Universitätsmedizin Mannheim Klinik für Strahlentherapie und Radioonkologie
Start Date
2021-03-05
Trial ID
NCT04495309
Treatments Being Tested
The current trial will test the combination of darolutamide with SBRT, in o...
Status
Unknown
Location
OLVZ Aalst
Start Date
2021-02-12
Trial ID
NCT04641078
Treatments Being Tested
This is a prospective, open-label, multi-center seamless phase II to phase ...
Status
Recruiting
Location
VA Long Beach Healthcare System, Long Beach, CA
Start Date
2021-07-01
Trial ID
NCT04787744
Treatments Being Tested
The aim is to investigate whether the addition of short-term androgen depri...
Status
Recruiting
Location
University Hospitals Leuven
Start Date
2022-04-20
Trial ID
NCT05352178
This phase II trial studies how well prostate specific membrane antigen (PS...
Status
Recruiting
Location
University of Pittsburgh Cancer Institute (UPCI)
Start Date
2020-09-30
Trial ID
NCT04175431
This is clinical trial evaluating the safety and efficacy of radiotherapy c...
Status
Not Yet Recruiting
Location
West China Hospital of Sichuan University
Start Date
2026-10-31
Trial ID
NCT07258147
In patients with metastatic prostate cancer (PCa) who receive androgen depr...
Status
Recruiting
Location
UMC Groningen
Start Date
2025-01-03
Trial ID
NCT07038304
Treatments Being Tested
This is a phase II trial aiming at assessing the efficacy of pembrolizumab ...
Status
Unknown
Location
Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Start Date
2023-03-14
Trial ID
NCT05578664